Hung-Jin Huang - Search Results

Year	Number of Results
2009	2
2010	3
2011	4
2012	2
2013	1
2014	14
2015	1
2017	1
2019	2
2020	1
2021	3
2022	1
2023	2
2024	0

1

Smart polymers for cell therapy and precision medicine.

Huang HJ, Tsai YL, Lin SH, Hsu SH. Huang HJ, et al. J Biomed Sci. 2019 Oct 18;26(1):73. doi: 10.1186/s12929-019-0571-4. J Biomed Sci. 2019. PMID: 31623607 Free PMC article. Review.

2

Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety.

Huang HJ, Chou CL, Sandar TT, Liu WC, Yang HC, Lin YC, Zheng CM, Chiu HW. Huang HJ, et al. Biomolecules. 2023 Oct 26;13(11):1581. doi: 10.3390/biom13111581. Biomolecules. 2023. PMID: 38002263 Free PMC article. Review.

3

Current Strategies in Assessment of Nanotoxicity: Alternatives to In Vivo Animal Testing.

Huang HJ, Lee YH, Hsu YH, Liao CT, Lin YF, Chiu HW. Huang HJ, et al. Int J Mol Sci. 2021 Apr 19;22(8):4216. doi: 10.3390/ijms22084216. Int J Mol Sci. 2021. PMID: 33921715 Free PMC article. Review.

4

Investigation of potential descriptors of chemical compounds on prevention of nephrotoxicity via QSAR approach.

Huang HJ, Lee YH, Chou CL, Zheng CM, Chiu HW. Huang HJ, et al. Comput Struct Biotechnol J. 2022 Apr 15;20:1876-1884. doi: 10.1016/j.csbj.2022.04.013. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 35521549 Free PMC article.

5

Key features for designing phosphodiesterase-5 inhibitors.

Chang TT, Huang HJ, Lee KJ, Yu HW, Chen HY, Tsai FJ, Sun MF, Chen CY. Chang TT, et al. Among authors: huang hj. J Biomol Struct Dyn. 2010 Dec;28(3):309-21. doi: 10.1080/07391102.2010.10507361. J Biomol Struct Dyn. 2010. PMID: 20919747

6

Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor.

Huang HJ, Lee YH, Sung LC, Chen YJ, Chiu YJ, Chiu HW, Zheng CM. Huang HJ, et al. Comput Struct Biotechnol J. 2023 Jul 7;21:3490-3502. doi: 10.1016/j.csbj.2023.07.007. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 37484490 Free PMC article.

7

Investigation of anti-infection mechanism of lactoferricin and splunc-1.

Tsou YA, Huang HJ, Lin WW, Chen CY. Tsou YA, et al. Among authors: huang hj. Evid Based Complement Alternat Med. 2014;2014:907028. doi: 10.1155/2014/907028. Epub 2014 Apr 30. Evid Based Complement Alternat Med. 2014. PMID: 24876880 Free PMC article.

8

Engineered Bacteriorhodopsin May Induce Lung Cancer Cell Cycle Arrest and Suppress Their Proliferation and Migration.

Wong CW, Ko LN, Huang HJ, Yang CS, Hsu SH. Wong CW, et al. Among authors: huang hj. Molecules. 2021 Dec 3;26(23):7344. doi: 10.3390/molecules26237344. Molecules. 2021. PMID: 34885925 Free PMC article.

9

Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches.

Huang HJ, Kraevaya OA, Voronov II, Troshin PA, Hsu SH. Huang HJ, et al. Int J Nanomedicine. 2020 Apr 14;15:2485-2499. doi: 10.2147/IJN.S243463. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32368036 Free PMC article.

10

Blocking the DNA repair system by traditional Chinese medicine?

Sun MF, Chang TT, Chang KW, Huang HJ, Chen HY, Tsai FJ, Lin JG, Chen CY. Sun MF, et al. Among authors: huang hj. J Biomol Struct Dyn. 2011 Jun;28(6):895-906. doi: 10.1080/07391102.2011.10508616. J Biomol Struct Dyn. 2011. PMID: 21469750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year